国际标准期刊号: 2576-3881

细胞因子生物学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Understanding Immunogenicity: The Key to Effective Vaccines and Therapies

Gautam Kumar

Immunogenicity, a fundamental concept in immunology, encompasses the ability of substances to induce an
immune response in the body. This article provides an overview of immunogenicity, emphasizing its significance
in vaccine development, biologics, and therapeutic proteins. Factors influencing immunogenicity, including antigen
characteristics, host factors, adjuvants, and dosing regimens, are explored. The complex interplay of these
factors shapes the strength and specificity of immune responses. In the context of vaccines, the article delves
into the pivotal role of immunogenicity in clinical trials, with a focus on achieving robust and durable protection
against targeted pathogens. In biologics and therapies, the impact of anti-drug antibodies on safety and efficacy
is discussed, alongside strategies to mitigate immunogenicity risks. The article concludes by highlighting ongoing
challenges in understanding individual immune responses and envisioning future directions, such as personalized
medicine approaches and innovative vaccine platforms, to optimize immunogenicity.